Torrent Pharmaceuticals Limited (TORNTPHARM) — Annual Report Announcement
Torrent Pharmaceuticals Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26 along with an Independent Reasonable Assurance Report from Grant Thornton Bharat LLP. The report details ESG performance across 9 principles, including climate action, water stewardship, waste reduction, and human rights. Key disclosures include 100% renewable energy targets, 88% waste recycled, 0.31% revenue spent on employee well-being, and 28% standalone export turnover. Governance is overseen by the Corporate Social Responsibility and Sustainability Committee, with policies aligned to NGRBC and global frameworks. No material financial changes or forward guidance were provided in the filing.
📄 View Original Announcement (PDF)
About Torrent Pharmaceuticals Limited (TORNTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.